Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by Evercore ISI with a $55.00 price target

Analyst Ratings For Adamas Pharmaceuticals Inc (NASDAQ:ADMS)

Story continues below

Today, Evercore ISI reiterated its Buy rating on Adamas Pharmaceuticals Inc (NASDAQ:ADMS) with a price target of $55.00.

There are 5 Buy Ratings, 3 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on Adamas Pharmaceuticals Inc (NASDAQ:ADMS) is Hold with a consensus target price of $25.1250 per share, a potential 315.29% upside.

Some recent analyst ratings include

  • 8/12/2019-Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by Evercore ISI with a $55.00 price target
  • 4/24/2019-Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Sell rating reiterated by Mizuho with a $5.00 price target
  • 3/5/2019-Adamas Pharmaceuticals Inc (NASDAQ:ADMS) had its Buy rating reiterated by Northland Securities with a $28.00 price target
  • 3/5/2019-Adamas Pharmaceuticals Inc (NASDAQ:ADMS) gets downgraded to Hold by Needham & Company LLC
  • 3/5/2019-Adamas Pharmaceuticals Inc (NASDAQ:ADMS) gets downgraded to Market Perform by Cowen with a price target of $15.00
  • On 7/22/2019 Christopher B Prentiss, Insider, sold 1,082 with an average share price of $6.00 per share and the total transaction amounting to $6,492.00.
  • On 6/20/2019 Jennifer J. Rhodes, Insider, sold 940 with an average share price of $5.35 per share and the total transaction amounting to $5,029.00.
  • On 3/20/2019 Alfred G Merriweather, CFO, sold 857 with an average share price of $7.99 per share and the total transaction amounting to $6,847.43.
  • On 3/20/2019 Christopher B Prentiss, Insider, sold 1,185 with an average share price of $8.00 per share and the total transaction amounting to $9,480.00.
  • On 3/20/2019 Gregory T Went, CEO, sold 6,319 with an average share price of $7.99 per share and the total transaction amounting to $50,488.81.
  • On 12/20/2018 Christopher B. Prentiss, CAO, sold 228 with an average share price of $7.51 per share and the total transaction amounting to $1,712.28.
  • On 12/20/2018 Jennifer J. Rhodes, Insider, sold 425 with an average share price of $7.52 per share and the total transaction amounting to $3,196.00.

Recent Trading Activity for Adamas Pharmaceuticals Inc (NASDAQ:ADMS)
Shares of Adamas Pharmaceuticals Inc closed the previous trading session at 6.05 −0.070 1.14% with 4.87 shares trading hands.

An ad to help with our costs